Posts Tagged ‘cancer treatment’
Revolutionary Breast Cancer Drug Provides Chemo Respite
The fight against cancer has been on going for generations. Treatment becomes more sophisticated by the day but still that one elusive cancer drug that would cure it all has not been found. That being said, many families have been able to spend extra months and years with their loved ones because of advancements in treatment. In breaking news, thanks to persistent research, doctors have discovered a new drug for breast cancer treatment.
Breakthrough in Triple Negative Breast Cancer Treatment
With October having come and gone, a new breakthrough in Triple Negative Beast Cancer treatment will no doubt add impetus to the awareness that the month encourages. Dr. Sam Aparicio of the British Columbia Cancer Agency recently led a study into the genetic makeup of the hard-to-treat form of breast cancer. Triple negative breast cancer is the deadliest form of breast cancers and the prognosis is generally bad news. Although it accounts for 16 percent of breast cancer types, it is the cause of a quarter of all breast cancer deaths.
More than 100 of such triple negative cancer tumours went through genetic sequencing and decoding, the result of which uncovered that there were an incredible number of variations and type and number of abnormalities. A strict set of regulatory affairs would naturally be considered.
Cancer Trial May Offer New Treatment to Head and Neck Cancer Sufferers
According to a new cancer trial, a harmless human virus that naturally occurs in the human body may be able to improve the effectiveness of two chemotherapy drugs in certain cancer patients. Early stage trial data recently published by Clinical Cancer Research showed that RT3D or Reolysin, a new cancer drug developed by Oncolytics Biotech Inc, had promising results in its preclinical and clinical studies conducted at The Institute of Cancer Research (ICR) and the Royal Marsden Hospital. These two institutes are known worldwide for their expertise in clinical research assistant jobs. The drug is largely based on the reovirus type 3 Dearing that is found in most adult respiratory and gastrointestinal tracts.
Breast Cancer Drug Trial to Start
Every year an estimated 9000 women in the UK are diagnosed with triple-negative breast cancer. Unfortunately the majority of these women do not respond to traditional breast cancer treatment, which is used to target other types of the disease. Triple-negative is also a particularly aggressive form of the disease which, when coupled with low response rate to the treatment, often results in early death.